Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

ANI Pharma Inc (NQ: ANIP )

64.90 +1.44 (+2.27%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 31, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 175,113
Open 63.62
Bid (Size) 64.82 (4)
Ask (Size) 64.96 (3)
Prev. Close 63.46
Today's Range 63.10 - 64.96
52wk Range 44.27 - 70.81
Shares Outstanding 24,422,240
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ANIP Stock Earnings: ANI Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024
ANIP stock results show that ANI Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Evaluating ANI Pharmaceuticals: Insights From 5 Financial Analysts
Via Benzinga

Performance

YTD
+13.48%
+13.48%
1 Month
-0.81%
-0.81%
3 Month
+9.76%
+9.76%
6 Month
+25.17%
+25.17%
1 Year
+40.63%
+40.63%

More News

Read More
Alphabet, Dover And 2 Other Stocks Insiders Are Selling
Via Benzinga
Expert Outlook: ANI Pharmaceuticals Through The Eyes Of 4 Analysts
Via Benzinga
Earnings Scheduled For February 29, 2024
Via Benzinga
Drug Maker Organon Stock Scores Relative Strength Upgrade
Via Investor's Business Daily
ANI Pharmaceuticals's Earnings Outlook
Via Benzinga
Expert Ratings for ANI Pharmaceuticals
Via Benzinga
Analyst Expectations for ANI Pharmaceuticals's Future
Via Benzinga
What 4 Analyst Ratings Have To Say About ANI Pharmaceuticals
Via Benzinga
Truist Securities Maintains Buy Rating for ANI Pharmaceuticals: Here's What You Need To Know
Via Benzinga
Why Is Generic Drug Player ANI Pharmaceuticals Stock Trading Lower Today?
Via Benzinga
ANI Pharmaceuticals Inc. (NASDAQ: ANIP) Records 52-Week High Wednesday Morning
Via Investor Brand Network
7 A-Rated Biotech Stocks for Your August Buy List
Via InvestorPlace
Where ANI Pharmaceuticals Stands With Analysts
Via Benzinga
Looking Into ANI Pharmaceuticals's Return On Capital Employed
Via Benzinga
Why ANI Pharmaceuticals Stock Is Soaring Today
Via Benzinga
ANI Pharmaceuticals to Present at the Jefferies Healthcare Conference
From ANI Pharmaceuticals, Inc.
Via Business Wire
ANI Pharmaceuticals Announces Closing of Public Offering of Common Stock Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
From ANI Pharmaceuticals, Inc.
Via Business Wire
ANI Pharmaceuticals Announces FDA Approval and Commercialization of Two ANDAs with CGT Exclusivity
From ANI Pharmaceuticals, Inc.
Via Business Wire
ANI Pharmaceuticals Announces Pricing of $75 Million Public Offering of Common Stock
From ANI Pharmaceuticals, Inc.
Via Business Wire
ANI Pharmaceuticals Announces Proposed Public Offering of Common Stock
From ANI Pharmaceuticals, Inc.
Via Business Wire
Stocks Reverse Gains Ahead Of Slew Of Inflation Data
Via Talk Markets
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Why Tredegar Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.